Ubrogepant

Records for this ingredient, by country (identity only).

ATC N02CD04 · 2 markets · 6 records

Ubrogepant 2 markets · 6 records Forms

Filters

MarketUS 4 CA 2

Strength

US 4 records · 2 shown of 2 Source openFDA NDC Directory · Data as of 2026-10-23

100 mgtabletUBRELVY also in CA
50 mgtabletUBRELVY also in CA

CA 2 records · 2 shown of 2 Source Health Canada Drug Product Databas · Data as of 2026-10-23

100 mgtabletUBRELVY also in US
50 mgtabletUBRELVY also in US

Side-by-side table

Strength / form / release	US	CA
100 mg tablet	UBRELVY	UBRELVY
50 mg tablet	UBRELVY	UBRELVY

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.